KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells.
cell differentiation
endothelial cells
fibroblast
hemangioma
stem cells
Journal
Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
revised:
08
12
2022
received:
11
08
2022
accepted:
20
12
2022
medline:
4
4
2023
pubmed:
27
12
2022
entrez:
26
12
2022
Statut:
ppublish
Résumé
Infantile hemangiomas are common vascular tumors with a specific natural history. The proliferation and regression mechanism of infantile hemangiomas may be related to the multilineage differentiation ability of hemangioma stem cells, but the specific mechanism is not well elucidated. KIAA1429 is an N
Identifiants
pubmed: 36572002
doi: 10.1111/cas.15708
pmc: PMC10067437
doi:
Substances chimiques
Virma protein, mouse
0
RNA-Binding Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1569-1581Subventions
Organisme : Clinical Medical Science Innovation Program of Jinan
ID : 202019076
Organisme : National Natural Science Foundation of China
ID : 82172227
Informations de copyright
© 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Références
J Clin Invest. 2001 Mar;107(6):745-52
pubmed: 11254674
JAAD Int. 2020 Jul 31;1(2):111-113
pubmed: 34409330
Plast Reconstr Surg. 1982 Mar;69(3):412-22
pubmed: 7063565
J Am Acad Dermatol. 2021 Dec;85(6):1379-1392
pubmed: 34419524
Mol Ther Nucleic Acids. 2021 Aug 19;27:133-146
pubmed: 34976433
Front Surg. 2014 Sep 25;1:38
pubmed: 25593962
J Clin Med. 2021 Oct 09;10(20):
pubmed: 34682753
Cancer Sci. 2023 Apr;114(4):1569-1581
pubmed: 36572002
Br J Dermatol. 2018 Sep;179(3):582-589
pubmed: 29774538
J Clin Pathol. 2010 Nov;63(11):982-6
pubmed: 20924092
Pathol Res Pract. 2017 Jun;213(6):591-597
pubmed: 28552538
Hum Pathol. 2000 Jan;31(1):11-22
pubmed: 10665907
Pediatrics. 2016 Apr;137(4):
pubmed: 26952504
J Cell Physiol. 2020 Oct;235(10):7420-7432
pubmed: 32052427
Metabolism. 2016 Feb;65(2):124-39
pubmed: 26773935
Mol Ther. 2020 Oct 7;28(10):2191-2202
pubmed: 32755566
Oncogene. 2019 Aug;38(33):6123-6141
pubmed: 31285549
Br J Dermatol. 2013 Jul;169(1):125-9
pubmed: 23659587
J Clin Pathol. 2011 Mar;64(3):232-6
pubmed: 21242328
J Clin Invest. 2008 Jul;118(7):2592-9
pubmed: 18535669
J Hematol Oncol. 2014 Jan 31;7:13
pubmed: 24479731
Br J Dermatol. 2013 Jul;169(1):188-91
pubmed: 23421718
Pediatrics. 2020 Apr;145(4):
pubmed: 32161112
Signal Transduct Target Ther. 2021 Feb 21;6(1):74
pubmed: 33611339
Cell Death Discov. 2022 Feb 25;8(1):83
pubmed: 35217651
J Cutan Pathol. 2000 Oct;27(9):441-50
pubmed: 11028814
Cancer Lett. 2021 Dec 1;522:142-154
pubmed: 34520821
N Engl J Med. 2008 Jun 12;358(24):2649-51
pubmed: 18550886
Plast Reconstr Surg. 2012 Sep;130(3):619-624
pubmed: 22575857
Lancet. 2017 Jul 1;390(10089):85-94
pubmed: 28089471
Eur J Pediatr. 2015 Jul;174(7):855-65
pubmed: 26021855
Br J Dermatol. 2011 May;164(5):1097-100
pubmed: 21518328
Mol Cancer. 2019 Nov 18;18(1):163
pubmed: 31735169
Mol Cancer. 2019 Dec 19;18(1):186
pubmed: 31856849
Pediatr Dermatol. 2013 Mar-Apr;30(2):182-91
pubmed: 23405852
Pediatrics. 2019 Jan;143(1):
pubmed: 30584062
J Hematol Oncol. 2011 Dec 22;4:54
pubmed: 22192404
Mol Cancer. 2019 May 29;18(1):103
pubmed: 31142332
Cell Discov. 2018 Feb 27;4:10
pubmed: 29507755
Blood. 2004 Feb 15;103(4):1373-5
pubmed: 14576053
J Plast Reconstr Aesthet Surg. 2011 Apr;64(4):445-51
pubmed: 20797926
Stem Cells. 2015 Jan;33(1):133-45
pubmed: 25187207
Br J Dermatol. 2013 Jul;169(1):12-9
pubmed: 23668474
Arch Dermatol Res. 2016 May;308(4):219-27
pubmed: 26940670
Pediatrics. 2009 Sep;124(3):e423-31
pubmed: 19706583